Equities

Enhabit Inc

Enhabit Inc

Actions
Health CareHealth Care Providers
  • Price (USD)10.25
  • Today's Change0.14 / 1.38%
  • Shares traded339.28k
  • 1 Year change-18.78%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 21:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Enhabit, Inc. is a provider of home health and hospice services. The Company’s segments include Home Health and Hospice. The Home Health segment provides a range of Medicare-certified skilled home health services, including skilled nursing, physical, occupational and speech therapy, medical social work, and home health aide services. Its home health business benefits from a diversity of referral sources, with patients referred from acute care hospitals, inpatient rehabilitation facilities, surgery centers, assisted living facilities, and skilled nursing facilities, as well as community physicians. The Hospice segment provides hospice services for terminally ill patients and their families. Its Medicare-certified hospice operations provide hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and family member bereavement counseling. It operates over 110 hospice agencies and 255 home health agencies.

  • Revenue in USD (TTM)1.05bn
  • Net income in USD-80.50m
  • Incorporated2014
  • Employees10.80k
  • Location
    Enhabit Inc6688 N. Central Expressway, Suite 1300DALLAS 75206United StatesUSA
  • Phone+1 (469) 621-6419
  • Fax+1 (302) 655-5049
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Viemed Healthcare Inc183.01m10.24m302.30m996.0030.762.649.411.650.25360.25364.532.961.3517.1210.82183,743.007.5312.289.2715.5261.6362.575.6010.091.05--0.07710.0031.8223.2164.631.5033.67--
Airsculpt Technologies Inc195.92m-4.48m313.00m346.00--3.7153.381.60-0.0793-0.07933.421.460.968--82.11566,234.10-2.21---2.47--65.23---2.29----2.760.4603--16.07--69.49------
DocGo Inc624.29m6.86m356.27m2.92k57.471.1813.450.57070.05950.05955.902.891.41--3.42214,164.202.27--3.33--31.30--1.61------0.1068--41.72---80.17------
Community Health Systems Inc12.49bn-133.00m386.37m61.00k----0.74020.0309-1.02-1.0295.76-10.180.85785.865.85204,770.500.10990.75660.13560.938184.0483.690.12810.93451.341.141.08--2.28-2.47-389.13---2.39--
Sonida Senior Living Inc255.32m-26.10m390.98m2.62k----28.351.53-3.57-3.5736.69-8.140.3981--36.1497,562.86-3.29-6.63-3.88-8.19-----8.27-18.04---0.50651.12--7.08-11.1155.74---3.97--
Aveanna Healthcare Holdings Inc1.90bn-134.52m415.54m3.50k------0.2193-0.7105-0.71059.99-0.66811.14--8.04541,488.30-8.09---10.18--31.4231.12-7.10-12.71--1.471.10--6.028.6279.68---20.76--
CareDx Inc280.32m-190.28m417.85m635.00--1.59--1.49-3.55-3.555.215.070.55525.274.78441,455.10-37.69-17.54-44.47-20.8563.6165.50-67.88-27.783.77--0.00---12.8929.63-148.37--5.01--
QDM International Inc6.53m1.69m466.21m3.0042.02143.15272.0671.360.0380.0380.02960.01121.81--148.49--46.82--127.17--38.10--25.81----1,761.140.2722--1,542.96--111.78------
Talkspace Inc150.05m-19.18m501.64m472.00--4.22--3.34-0.1171-0.11710.90930.70441.01--15.15317,891.90-12.85---15.38--49.57---12.78------0.00--25.49--75.92------
Enhabit Inc1.05bn-80.50m506.81m10.80k--0.7556--0.4844-1.62-1.6220.9313.380.7069--6.6696,879.63-5.34---6.02--48.81---7.55----0.62790.4406---2.32---99.26------
InnovAge Holding Corp720.80m-31.56m543.60m2.10k--1.90--0.7542-0.2326-0.23265.312.101.33--17.56343,236.20-6.31---8.38--16.48---4.73-----4.190.2146---1.51---523.72------
Auna SAA1.04bn-68.37m549.21m14.96k--1.3995.280.5262-0.925-0.92514.125.34------69,773.90---1.32---2.0337.0336.81-5.53-2.220.83981.050.6881--58.1035.10-196.62--28.94--
Diversified Healthcare Trust1.41bn-293.57m567.39m0.00--0.242851.710.4023-1.23-1.235.909.720.2464--190.62---4.77-1.04-4.82-1.0616.7524.43-19.37-4.93---0.44050.5466--9.874.77-1,761.11--0.1461-51.94
Pennant Group Inc544.89m13.38m604.48m5.79k44.904.2431.751.110.44290.442918.054.691.04--9.5194,092.732.641.813.092.1420.1021.622.551.92--3.940.30520.0015.1413.76101.40-3.1314.07--
Accolade Inc388.49m-122.73m709.83m2.37k--1.62--1.83-1.65-1.655.225.650.4572--15.62163,918.10-14.45-31.21-16.73-37.4944.8144.36-31.59-69.22----0.3238--17.1336.43-273.32--0.2088--
Data as of Apr 19 2024. Currency figures normalised to Enhabit Inc's reporting currency: US Dollar USD

Institutional shareholders

58.81%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 31 Dec 20237.50m14.97%
The Vanguard Group, Inc.as of 31 Dec 20235.63m11.24%
AREX Capital Management LPas of 31 Dec 20232.41m4.82%
Van Lanschot Kempen Investment Management NVas of 31 Dec 20232.21m4.40%
JANA Partners Management LPas of 31 Dec 20232.08m4.16%
SSgA Funds Management, Inc.as of 31 Dec 20232.01m4.01%
Paradice Investment Management LLCas of 31 Dec 20232.00m4.00%
Scopia Capital Management LPas of 31 Dec 20231.94m3.86%
Dimensional Fund Advisors LPas of 31 Dec 20231.87m3.72%
LOYS AGas of 29 Feb 20241.83m3.64%
More ▼
Data from 31 Dec 2023 - 29 Feb 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.